C. L. Allen and U. Bayraktutan, Risk Factors for Ischaemic Stroke, International Journal of Stroke, vol.111, issue.2, pp.105-116, 2008.
DOI : 10.1161/01.CIR.0000157736.19739.D0

M. J. Luitse, G. J. Biessels, G. E. Rutten, and L. Kappelle, Diabetes, hyperglycaemia, and acute ischaemic stroke, The Lancet Neurology, vol.11, issue.3, pp.261-271, 2012.
DOI : 10.1016/S1474-4422(12)70005-4

C. Albert-weissenberger, A. L. Siren, and C. Kleinschnitz, Ischemic stroke and traumatic brain injury: The role of the kallikrein???kinin system, Progress in Neurobiology, vol.101, issue.102, pp.65-82, 2013.
DOI : 10.1016/j.pneurobio.2012.11.004

K. P. Doyle, R. P. Simon, and M. P. Stenzel-poore, Mechanisms of ischemic brain damage, Neuropharmacology, vol.55, issue.3, pp.310-318, 2008.
DOI : 10.1016/j.neuropharm.2008.01.005

N. E. Rhaleb, X. P. Yang, and O. A. Carretero, The Kallikrein-Kinin System as a Regulator of Cardiovascular and Renal Function, Compr Physiol, vol.51, issue.Suppl 20, pp.971-993, 2011.
DOI : 10.1161/01.RES.51.3.385

L. M. Leeb-lundberg, F. Marceau, W. Muller-esterl, D. J. Pettibone, and B. L. Zuraw, International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences, Pharmacological Reviews, vol.57, issue.1, pp.27-77, 2005.
DOI : 10.1124/pr.57.1.2

Y. Kayashima, O. Smithies, and M. Kakoki, The kallikrein???kinin system and oxidative stress, Current Opinion in Nephrology and Hypertension, vol.21, issue.1, pp.92-96, 2012.
DOI : 10.1097/MNH.0b013e32834d54b1
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657726

J. P. Girolami, N. Blaes, N. Bouby, and F. Alhenc-gelas, Genetic Manipulation and Genetic Variation of the Kallikrein-Kinin System: Impact on Cardiovascular and Renal Diseases, Prog Drug Res, vol.69, pp.145-196, 2014.
DOI : 10.1007/978-3-319-06683-7_6

V. Griol-charhbili, Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocardial ischemia, The FASEB Journal, vol.19, pp.1172-1174, 2005.
DOI : 10.1096/fj.04-3508fje

M. Kakoki, R. W. Mcgarrah, H. S. Kim, and O. Smithies, Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury, Proceedings of the National Academy of Sciences, vol.99, issue.7, pp.7576-7581, 2007.
DOI : 10.1073/pnas.072083799
URL : http://www.pnas.org/content/104/18/7576.full.pdf

L. Potier, Selective Kinin Receptor Agonists as Cardioprotective Agents in Myocardial Ischemia and Diabetes, Journal of Pharmacology and Experimental Therapeutics, vol.346, issue.1, pp.23-30, 2013.
DOI : 10.1124/jpet.113.203927

D. Desposito, Kinin Receptor Agonism Restores Hindlimb Postischemic Neovascularization Capacity in Diabetic Mice, Journal of Pharmacology and Experimental Therapeutics, vol.352, issue.2, pp.218-226, 2015.
DOI : 10.1124/jpet.114.219196
URL : http://jpet.aspetjournals.org/content/jpet/352/2/218.full.pdf

K. Kizuki, T. Suzuki, M. Kudo, and T. Noguchi, Immunohistochemical demonstration of tissue kallikrein in the neurons of rat brain, Brain Research, vol.634, issue.2, pp.305-309, 1994.
DOI : 10.1016/0006-8993(94)91934-8

K. Walker, M. Perkins, and A. Dray, Kinins and kinin receptors in the nervous system, Neurochemistry International, vol.26, issue.1, pp.1-16, 1995.
DOI : 10.1016/0197-0186(94)00114-A

D. M. Raidoo, Visualisation of bradykinin B2 receptors on human brain neurons, Immunopharmacology, vol.33, issue.1-3, pp.104-107, 1996.
DOI : 10.1016/0162-3109(96)00021-5

D. M. Raidoo and K. D. Bhoola, Kinin receptors on human neurones, Journal of Neuroimmunology, vol.77, issue.1, pp.39-44, 1997.
DOI : 10.1016/S0165-5728(97)00048-9

B. Ongali, Autoradiographic analysis of rat brain kinin B1 and B2 receptors: Normal distribution and alterations induced by epilepsy, The Journal of Comparative Neurology, vol.273, issue.4, pp.506-519, 2003.
DOI : 10.1002/cne.10706

R. Trabold, Receptors for Secondary Brain Damage after Traumatic Brain Injury in Mice, Journal of Cerebral Blood Flow & Metabolism, vol.232, issue.1, pp.130-139, 2010.
DOI : 10.1089/089771503322686102

M. Groger, Receptors in the Brain: Role for Cell Death and Brain Edema Formation After Focal Cerebral Ischemia in Mice, Journal of Cerebral Blood Flow & Metabolism, vol.950, issue.8, pp.978-989, 2005.
DOI : 10.1089/089771503322686102

M. Austinat, Blockade of Bradykinin Receptor B1 but Not Bradykinin Receptor B2 Provides Protection From Cerebral Infarction and Brain Edema * Expanded Materials and Methods, Stroke, vol.40, issue.1, pp.285-293, 2009.
DOI : 10.1161/STROKEAHA.108.526673

V. Bovenzi, Bradykinin protects against brain microvascular endothelial cell death induced by pathophysiological stimuli, Journal of Cellular Physiology, vol.280, issue.1, pp.168-176, 2010.
DOI : 10.4049/jimmunol.179.3.1834

J. K. Relton, V. E. Beckey, W. L. Hanson, and E. Whalley, CP-0597, a Selective Bradykinin B2 Receptor Antagonist, Inhibits Brain Injury in a Rat Model of Reversible Middle Cerebral Artery Occlusion, Stroke, vol.28, issue.7, pp.1430-1436, 1997.
DOI : 10.1161/01.STR.28.7.1430

L. Ding-zhou, receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia, British Journal of Pharmacology, vol.950, issue.Suppl, pp.1539-1547, 2003.
DOI : 10.1038/jcbfm.1984.82

B. Klasner, D. B. Lumenta, D. Pruneau, S. Zausinger, and N. Plesnila, Therapeutic window of bradykinin B2 receptor inhibition after focal cerebral ischemia in rats, Neurochemistry International, vol.49, issue.5, pp.442-447, 2006.
DOI : 10.1016/j.neuint.2006.02.010

J. Chao and L. Chao, Kallikrein-kinin in stroke, cardiovascular and renal disease, Experimental Physiology, vol.104, issue.3, pp.291-298, 2005.
DOI : 10.1093/oxfordjournals.aje.a112282
URL : http://onlinelibrary.wiley.com/doi/10.1113/expphysiol.2004.028464/pdf

C. F. Xia, Postischemic Brain Injury Is Exacerbated in Mice Lacking the Kinin B2 Receptor, Hypertension, vol.47, issue.4, pp.752-761, 2006.
DOI : 10.1161/01.HYP.0000214867.35632.0e

V. Danielisova, M. Gottlieb, P. Bonova, M. Nemethova, and J. Burda, Bradykinin postconditioning ameliorates focal cerebral ischemia in the rat, Neurochemistry International, vol.72, pp.22-29, 2014.
DOI : 10.1016/j.neuint.2014.04.005

I. Duka, Vasoactive Potential of the B1 Bradykinin Receptor in Normotension and Hypertension, Circulation Research, vol.88, issue.3, pp.275-281, 2001.
DOI : 10.1161/01.RES.88.3.275

R. Marcon, receptors: the role of tight junctions and intestinal homeostasis, British Journal of Pharmacology, vol.45, issue.2, pp.389-402, 2013.
DOI : 10.1161/01.HYP.0000153322.04859.81

H. Sang, Opposite roles of bradykinin B1 and B2 receptors during cerebral ischaemia-reperfusion injury in experimental diabetic rats, European Journal of Neuroscience, vol.4, issue.Pt 1, pp.53-65, 2016.
DOI : 10.1016/S0006-8993(02)03053-6

C. Tschope, Upregulation of bradykinin B1-receptor expression after myocardial infarction, British Journal of Pharmacology, vol.44, issue.8, pp.1537-1538, 2000.
DOI : 10.1111/j.1476-5381.1995.tb16357.x

M. M. Campos, G. E. Souza, and J. B. Calixto, kinin-receptor upregulation. Evidence for involvement of protein kinases and nuclear factor ??B pathways, British Journal of Pharmacology, vol.16, issue.8, pp.1851-1859, 1999.
DOI : 10.1161/01.HYP.31.1.248

S. Matsumoto, M. Yamasaki, T. Kanno, T. Nagayama, and T. Shimizu, The Reflex Bradycardia during Brain Ischemia in the Rabbit., The Japanese Journal of Physiology, vol.41, issue.5, pp.703-715, 1991.
DOI : 10.2170/jjphysiol.41.703

M. Dobrivojevic, K. Spiranec, and A. Sindic, Involvement of bradykinin in brain edema development after ischemic stroke, Pfl??gers Archiv - European Journal of Physiology, vol.8, issue.2, pp.201-212, 2015.
DOI : 10.1016/j.intimp.2007.10.001

D. Desposito, Improvement of skin wound healing in diabetic mice by kinin B2 receptor blockade, Clinical Science, vol.130, issue.1, pp.45-56, 2016.
DOI : 10.1042/CS20150295
URL : https://hal.archives-ouvertes.fr/hal-01288792

M. A. Samuels, The Brain-Heart Connection, Circulation, vol.116, issue.1, pp.77-84, 2007.
DOI : 10.1161/CIRCULATIONAHA.106.678995

F. Alhenc-gelas, S. J. Tsai, K. S. Callahan, W. B. Campbell, and A. Johnson, Stimulation of prostaglandin formation by vasoactive mediators in cultured human endothelial cells, Prostaglandins, vol.24, issue.5, pp.723-742, 1982.
DOI : 10.1016/0090-6980(82)90040-5

R. F. Furchgott and P. M. Vanhoutte, Endothelium-derived relaxing and contracting factors, FASEB J, vol.3, pp.2007-2018, 1989.

N. J. Brown, J. V. Gainer, L. J. Murphey, and D. E. Vaughan, Bradykinin Stimulates Tissue Plasminogen Activator Release From Human Forearm Vasculature Through B2 Receptor-Dependent, NO Synthase-Independent, and Cyclooxygenase-Independent Pathway, Circulation, vol.102, issue.18, pp.2190-2196, 2000.
DOI : 10.1161/01.CIR.102.18.2190

S. S. Park, H. Zhao, R. A. Mueller, and Z. Xu, Bradykinin prevents reperfusion injury by??targeting mitochondrial permeability transition pore through glycogen synthase kinase 3??, Journal of Molecular and Cellular Cardiology, vol.40, issue.5, pp.708-716, 2006.
DOI : 10.1016/j.yjmcc.2006.01.024

G. Youcef, Tissue kallikrein is required for the cardioprotective effect of Cyclosporin A in myocardial ischemia in the mouse, Biochemical Pharmacology, vol.94, issue.1, pp.22-29, 2015.
DOI : 10.1016/j.bcp.2015.01.007

F. Alhenc-gelas, J. Marchetti, J. Allegrini, P. Corvol, and J. Menard, Measurement of urinary kallikrein activity species differences in kinin production, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.677, issue.3-4, pp.477-488, 1981.
DOI : 10.1016/0304-4165(81)90262-2

A. C. Paiva, T. B. Paiva, C. C. Pereira, and S. I. Shimuta, Selectivity of bradykinin analogues for receptors mediating contraction and relaxation of the rat duodenum, British Journal of Pharmacology, vol.6, issue.1, pp.206-210, 1989.
DOI : 10.1016/0196-9781(85)90033-6

S. Meini, A. Lecci, and C. A. Maggi, The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors, British Journal of Pharmacology, vol.205, issue.8, pp.1619-1624, 1996.
DOI : 10.1016/0014-2999(91)90824-A

A. Ni, -bradykinin and Susceptibility to Inflammation, Journal of Biological Chemistry, vol.17, issue.1, pp.219-225, 2003.
DOI : 10.1016/0014-2999(89)90661-4
URL : https://hal.archives-ouvertes.fr/hal-00854678

P. Meneton, Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice, Proceedings of the National Academy of Sciences, vol.100, issue.23, pp.2634-2639, 2001.
DOI : 10.1161/01.CIR.100.23.2359
URL : http://www.pnas.org/content/98/5/2634.full.pdf

F. Trabold, Cardiovascular Phenotypes of Kinin B2 Receptor- and Tissue Kallikrein-Deficient Mice, Hypertension, vol.40, issue.1, pp.90-95, 2002.
DOI : 10.1161/01.HYP.0000021747.43346.95
URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.541.7990

E. Rousselet, J. Kriz, and N. G. Seidah, Mouse Model of Intraluminal MCAO: Cerebral Infarct Evaluation by Cresyl Violet Staining, Journal of Visualized Experiments, issue.69, 2012.
DOI : 10.3791/4038

J. Cote, Novel kinin B1 receptor agonists with improved pharmacological profiles, Peptides, vol.30, issue.4, pp.788-795, 2009.
DOI : 10.1016/j.peptides.2008.12.018

S. Belanger, Structure???activity relationships of novel peptide agonists of the human bradykinin B2 receptor, Peptides, vol.30, issue.4, pp.777-787, 2009.
DOI : 10.1016/j.peptides.2008.12.003

L. Waeckel, Antihypertensive Role of Tissue Kallikrein in Hyperaldosteronism in the Mouse, Endocrinology, vol.153, issue.8, pp.3886-3896, 2012.
DOI : 10.1210/en.2012-1225

A. J. Hunter, Functional assessments in mice and rats after focal stroke, Neuropharmacology, vol.39, issue.5, pp.806-816, 2000.
DOI : 10.1016/S0028-3908(99)00262-2

T. Schallert, Behavioral tests for preclinical intervention assessment, NeuroRX, vol.44, issue.4, pp.497-504, 2006.
DOI : 10.1037/h0084244
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593401

M. Balkaya, J. M. Krober, A. Rex, and M. Endres, Assessing Post-Stroke Behavior in Mouse Models of Focal Ischemia, Journal of Cerebral Blood Flow & Metabolism, vol.50, issue.3, pp.330-338, 2013.
DOI : 10.1046/j.1601-1848.2001.00005.x

C. N. Joshi, S. K. Jain, and P. S. Murthy, An optimized triphenyltetrazolium chloride method for identification of cerebral infarcts, Brain Research Protocols, vol.13, issue.1, pp.11-17, 2004.
DOI : 10.1016/j.brainresprot.2003.12.001

S. Okuno, H. Nakase, and T. Sakaki, Comparative study of 2,3,5-triphenyltetrazolium chloride (TTC) and hematoxylin???eosin staining for quantification of early brain ischemic injury in cats, Neurological Research, vol.10, issue.6, pp.657-661, 2001.
DOI : 10.1161/01.STR.7.5.454

A. J. Baker, Hypothermia prevents ischemia-induced increases in hippocampal glycine concentrations in rabbits, Stroke, vol.22, issue.5, pp.666-673, 1991.
DOI : 10.1161/01.STR.22.5.666

S. Hatashita, J. T. Hoff, and S. M. Salamat, Ischemic Brain Edema and the Osmotic Gradient between Blood and Brain, Journal of Cerebral Blood Flow & Metabolism, vol.3, issue.4, pp.552-559, 1988.
DOI : 10.1016/0165-0270(80)90031-X

K. Zweckberger, Effect of Early and Delayed Decompressive Craniectomy on Secondary Brain Damage after Controlled Cortical Impact in Mice, Journal of Neurotrauma, vol.23, issue.7, pp.1083-1093, 2006.
DOI : 10.1089/neu.2006.23.1083

S. Bodin, Kallikrein protects against microalbuminuria in experimental type I diabetes, Kidney International, vol.76, issue.4, pp.395-403, 2009.
DOI : 10.1038/ki.2009.208
URL : http://doi.org/10.1038/ki.2009.208

K. J. Livak and T. Schmittgen, Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2???????CT Method, Methods, vol.25, issue.4, pp.402-408, 2001.
DOI : 10.1006/meth.2001.1262